Stewart v. Takeda Pharmaceutical Company Limited et al
| Tina Stewart and Sarah Stewart |
| Takeda Pharmaceuticals America, Inc.,, Takeda Pharmaceutical Company Limited and Takeda pharmaceuticals U.S.A., Inc. |
| 1:2020cv02768 |
| May 7, 2020 |
| U.S. District Court for the Northern District of Illinois |
| Robert M Dow |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 26, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 7
ORDER ORDER Fourth Amended General Order 20-0012 IN RE: CORONAVIRUS COVID-19 PUBLIC EMERGENCY Signed by the Chief Judge Rebecca R. Pallmeyer on May 26, 2020. This Order does not extend or modify any deadlines set in civil cases. For non-emergency motions, no motion may be noticed for presentment on a date earlier than July 15, 2020. See attached Order. Signed by the Honorable Rebecca R. Pallmeyer on 5/26/2020: Mailed notice. (docket11, )
|
|
Filing 8
EXECUTIVE COMMITTEE ORDER: It appearing that, for reasons of judicial efficiency, coordinated pretrial proceedings in the case listed below should be presided over by a single district judge as provided for by IOP13(e) and that a single magistrate judge should be designated for this case; and It further appearing that the Hon. Matthew F. Kennelly, has agreed to preside over these proceedings; and It further appearing that Magistrate Judge Young B. Kim has agreed to be the designated magistrate judge in these proceedings; therefore It is hereby ordered that Judge Kennelly shall preside over pretrial proceedings, including case management and discovery supervision, in the case listed below; and It is further ordered that Magistrate Judge Kim shall be the designated magistrate judge; and It is further ordered that this case shall remain pending on the calendar of the judge to whom it is currently assigned, and that an order be entered in each case by Judge Kennelly at such time as coordinated pretrial proceedings have concluded; and It is further ordered that the Clerk of Court shall open a new civil case (20 CV 623, In Re: Uloric Products Liability Coordinated Pretrial Proceedings) under which all future filings related to these coordinated pretrial proceedings shall be filed; and It is further ordered that the Clerk of Court shall link the individual case listed below to 20 CV 623, In Re: Uloric Products Liability Coordinated Pretrial Proceedings. Signed by the Executive Committee on 5/21/2020. Mailed notice (td, )
|
| Filing 6 MINUTE entry before the Honorable Robert M. Dow, Jr: Initial status hearing is set for 7/8/2020 at 9:00 a.m. and parties are to report the following: (1) Possibility of settlement in the case; (2) If no possibility of settlement exists, the nature and length of discovery necessary to get the case ready for trial. Plaintiff is to advise all other parties of the Courts action herein. Lead counsel is directed to appear at this status hearing. The parties are requested to file a joint status report at least three days prior to the initial status and all further status hearings. For further details see the Court's website available at www.ilnd.uscourts.gov. Mailed notice (cdh, ) |
| Filing 5 NOTICE TO THE PARTIES - The Court is participating in the Mandatory Initial Discovery Pilot (MIDP). The key features and deadlines are set forth in this Notice which includes a link to the (MIDP) Standing Order and a Checklist for use by the parties. In cases subject to the pilot, all parties must respond to the mandatory initial discovery requests set forth in the Standing Order before initiating any further discovery in this case. Please note: The discovery obligations in the Standing Order supersede the disclosures required by Rule 26(a)(1). Any party seeking affirmative relief must serve a copy of the following documents (Notice of Mandatory Initial Discovery and the Standing Order) on each new party when the Complaint, Counterclaim, Crossclaim, or Third-Party Complaint is served. (tg, ) |
| Filing 3 ATTORNEY Appearance for Plaintiff Sarah Stewart by Lisa Causey-Streete (Causey-Streete, Lisa) |
| Filing 2 CIVIL Cover Sheet (Causey-Streete, Lisa) |
| Filing 1 COMPLAINT filed by Sarah Stewart; Jury Demand. Filing fee $ 400, receipt number 0752-16994555.(Causey-Streete, Lisa) |
| CASE ASSIGNED to the Honorable Robert M. Dow, Jr. Designated as Magistrate Judge the Honorable Young B. Kim. Case assignment: Random assignment. (txl, ) |
| SUMMONS Issued as to Defendants Takeda Pharmaceuticals America, Inc.,, Takeda pharmaceuticals U.S.A., Inc. (ng, ) |
|
Filing 4
ORDER Third Amended General Order 20-0012 IN RE: CORONAVIRUS COVID-19 PUBLIC EMERGENCY Signed by the Chief Judge Rebecca R. Pallmeyer on April 24, 2020. All open cases are impacted by this Third Amended General Order. Parties are must carefully review all obligations under this Order, including the requirement listed in paragraph number 5 to file a joint written status report in most civil cases. See attached Order. Signed by the Honorable Rebecca R. Pallmeyer on 4/24/2020: Mailed notice (ec, )
|
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
